How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

July 23, 2026

New guidance launched to help Europe detect respiratory virus threats earlier

The guidance sets out practical surveillance objectives, outlines the epidemiological and virological systems needed to

July 23, 2026 No Comments

A man in the Lviv region tested positive for hantavirus after a trip to Croatia

A case of hantavirus infection has been confirmed in Lviv Oblast in a 53-year-old resident

July 23, 2026 No Comments

Early Release – Doxycycline Resistance and 16S rRNA Mutations in Treponema pallidum (Response) – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

July 23, 2026 No Comments

‘Loop’hole: HIV-1 hijacks human immune cells using circular RNAs

In a groundbreaking discovery, researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine

July 23, 2026 No Comments

Early Release – Correction: Vol. 32, No. 2 – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Correction: Vol. 32, No. 2 Volume 32, Number 8—August 2026 Article Views: 24 Data is

July 23, 2026 No Comments

New guidance launched to help Europe detect respiratory virus threats earlier

A man in the Lviv region tested positive for hantavirus after a trip to Croatia

Early Release – Doxycycline Resistance and 16S rRNA Mutations in Treponema pallidum (Response) – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

‘Loop’hole: HIV-1 hijacks human immune cells using circular RNAs

Early Release – Correction: Vol. 32, No. 2 – Volume 32, Number 8—August 2026 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us